5 mg/ml (Please refer to the vial label for the specific concentration.)
Canine IgG isotype control
Inclusion of an appropriate isotype control is essential for the proper interpretation of experimental results. Because isotype control antibodies have no relevant specificity, they enable the researcher to distinguish non-specific "background" binding from antigen-specific antibody binding. Non-specific binding of primary antibodies may occur due to either binding of antibody to Fc receptors or non-specific interactions with cellular proteins, lipids, or carbohydrates. Additionally, autofluorescence or endogenous enzyme activity in target cells may give a false positive that could be misinterpreted as antibody binding. These factors vary by target cell type and the isotype of the primary antibody. Therefore, the primary antibody used should be matched to an isotype control of identical species and isotype (including both heavy and light chains).
Negative control for Canine IgG, Canine IgG negative control, Isotype control to Canine IgG, Canine isotype control for IgG, Canine negative control for IgG, Isotype control for Canine IgG, Polyclonal Canine IgG isotype control, Canine IgG isotype
Antibodies Isotype Control
Source / Host
Store as concentrated solution. Centrifuge briefly prior to opening vial. Store at 4-8ºC.
Substrate / Buffer
100 mM borate buffered saline, pH 8.2
For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Product Page Updated
The delivery time for this item is approximately 7-10 business days. If other deviations occur, this will be noted on the order confirmation or communicated via email. Please note, we do reserve the right to select the best packaging and shipping method in order to insure the stability of the product and allow efficient order tracking.